SIC OpenIR
Optimal Zn-Modified Ca-Si-Based Ceramic Nanocoating with Zn Ion Release for Osteoblast Promotion and Osteoclast Inhibition in Bone Tissue Engineering
Yu, Jiangming1,2; Xu, Lizhang1; Xie, Ning1; Li, Kai3; Xi, Yanhai1; Liu, Xiling1; Zheng, Xuebin3; Chen, Xiongsheng1; Ye, Xiaojian1; Wei, Daixu4
2017
Source PublicationJournal of Nanomaterials
ISSN16874110
Volume2017
AbstractWe investigated the slow release of Zn ion (Zn2+) from nanocoatings and compared the in vitro response of osteoblasts (MC3T3-E1) and proosteoclasts (RAW 264.7) cultured on Ca2ZnSi2O7nanocoated with different Zn/Ca molar ratios on a Ti-6Al-4V (i.e., Ti) substrate to optimize cell behaviors and molecule levels. Significant morphology differences were observed among samples. By comparing with pure Ti and CaSiO3nanocoating, the morphology of Ca2ZnSi2O7ceramic nanocoatings was rough and contained small nanoparticles or aggregations. Slow Zn2+release from nanocoatings was observed and Zn2+concentration was regulated by varying the Zn/Ca ratios. The cell-response results showed Ca2ZnSi2O7nanocoating at different Zn/Ca molar ratios for osteoblasts and osteoclasts. Compared to other nanocoatings and Ti, sample Zn/Ca (0.3) showed the highest cell viability and upregulated expression of the osteogenic differentiation genes ALP, COL-1, and OCN. Additionally, sample Zn/Ca (0.3) showed the greatest inhibition of RAW 264.7 cell growth and decreased the mRNA levels of osteoclast-related genes OAR, TRAP, and HYA1. Therefore, the optimal Zn-Ca ratio of 0.3 in Ca2ZnSi2O7ceramic nanocoating on Ti had a dual osteoblast-promoting and osteoclast-inhibiting effect to dynamically balance osteoblasts/osteoclasts. These optimal Zn-Ca ratios are valuable for Ca2ZnSi2O7ceramic nanocoating on Ti-coated implants for potential applications in bone tissue regeneration. © 2017 Jiangming Yu et al.
DOI10.1155/2017/7374510
EI Accession Number20171303490876
EI KeywordsTitanium
EI Classification Number461 Bioengineering and Biology - 541.2 Aluminum Alloys - 542.3 Titanium and Alloys - 543.6 Vanadium and Alloys - 812.1 Ceramics
Citation statistics
Cited Times:1[WOS]   [WOS Record]     [Related Records in WOS]
Document Type期刊论文
Identifierhttp://ir.sic.ac.cn/handle/331005/25578
Collection中国科学院上海硅酸盐研究所
Affiliation1.Department of Orthopaedics, Changzheng Hospital, Second Military Medical University, Shanghai; 200003, China;
2.National Engineering Research Center for Nanotechnology, Shanghai; 200241, China;
3.Key Laboratory of Inorganic Coating Materials, Shanghai Institute of Ceramics, Chinese Academy of Sciences, Shanghai; 200003, China;
4.Tsinghua-Peking Center for Life Sciences, Tsinghua University, Beijing; 100084, China
Recommended Citation
GB/T 7714
Yu, Jiangming,Xu, Lizhang,Xie, Ning,et al. Optimal Zn-Modified Ca-Si-Based Ceramic Nanocoating with Zn Ion Release for Osteoblast Promotion and Osteoclast Inhibition in Bone Tissue Engineering[J]. Journal of Nanomaterials,2017,2017.
APA Yu, Jiangming.,Xu, Lizhang.,Xie, Ning.,Li, Kai.,Xi, Yanhai.,...&Wei, Daixu.(2017).Optimal Zn-Modified Ca-Si-Based Ceramic Nanocoating with Zn Ion Release for Osteoblast Promotion and Osteoclast Inhibition in Bone Tissue Engineering.Journal of Nanomaterials,2017.
MLA Yu, Jiangming,et al."Optimal Zn-Modified Ca-Si-Based Ceramic Nanocoating with Zn Ion Release for Osteoblast Promotion and Osteoclast Inhibition in Bone Tissue Engineering".Journal of Nanomaterials 2017(2017).
Files in This Item:
There are no files associated with this item.
Related Services
Recommend this item
Bookmark
Usage statistics
Export to Endnote
Google Scholar
Similar articles in Google Scholar
[Yu, Jiangming]'s Articles
[Xu, Lizhang]'s Articles
[Xie, Ning]'s Articles
Baidu academic
Similar articles in Baidu academic
[Yu, Jiangming]'s Articles
[Xu, Lizhang]'s Articles
[Xie, Ning]'s Articles
Bing Scholar
Similar articles in Bing Scholar
[Yu, Jiangming]'s Articles
[Xu, Lizhang]'s Articles
[Xie, Ning]'s Articles
Terms of Use
No data!
Social Bookmark/Share
All comments (0)
No comment.
 

Items in the repository are protected by copyright, with all rights reserved, unless otherwise indicated.